| Financial Year |
March 31 2023 |
| Monetary Funds |
1,676,370,596.69 |
| Held-for-trading Financial Assets |
599,912,843.99 |
| Notes Receivable |
1,137,568.12 |
| Accounts Receivable |
1,538,847,972.31 |
| Advances to Suppliers |
212,773,356.38 |
| Other Receivables |
97,484,719.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
298,092,104.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,523,776.68 |
| Other Current Assets |
165,639,167.46 |
| Total Current Assets |
5,437,436,052.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,677,090,508.36 |
| Investment Properties |
119,529,413.66 |
| Fixed Assetes |
9,447,965,950.68 |
| Under-construction Projects |
648,645,021.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,190,469,619.18 |
| R&D expenses |
1,634,889.09 |
| Goodwill |
3,062,477,841.23 |
| Long-Term Deferred and Prepaid Expenses |
32,294,307.38 |
| Deferred Income Tax Assets |
82,862,659.27 |
| Other Non-Current Assets |
68,341,314.28 |
| Sub-Total of Non-Current Assets |
17,057,126,652.41 |
| Total Assets |
22,494,562,704.80 |
| Short-Term Loans |
2,592,914,513.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
383,329,242.39 |
| Accounts Payable |
1,027,711,987.88 |
| Accounts Received In Advance |
4,325,376.11 |
| Employee Compensation Payable |
85,119,046.23 |
| Taxes Payable |
78,594,191.20 |
| Interest Payable |
-- |
| Dividend Payable |
10,722,878.70 |
| Other payables |
549,962,337.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,165,485,342.41 |
| Other Current Liabilities |
32,420,908.89 |
| Sub-Total of Current Liabilities |
6,192,766,405.37 |
| Long-term Loans |
3,339,140,000.00 |
| Bonds Payable |
1,000,000,000.00 |
| Long-Term Accounts Payable |
18,695,347.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,871,151.20 |
| Deferred Income Tax Liabilities |
284,852,453.15 |
| Other Non-Current Liabilities |
4,957,287.02 |
| Sub-Total of Non-Current Liabilities |
5,035,831,915.19 |
| Total Liabilities |
11,228,598,320.56 |
| Paid-In Capital(Or Share Stock) |
1,912,142,904.00 |
| Capital Surplus |
6,557,899,570.78 |
| Surplus Reserve |
286,072,826.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,349,216,811.92 |
| Minority Stockholder's Interest |
245,800,570.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,020,163,813.38 |
| Owner's Equity（Stockholder's Equity） |
11,265,964,384.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,494,562,704.80 |
